{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2017-07-12&houseId=1&tablingMemberConstituency=Mid+Derbyshire", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?date=2017-07-12&houseId=1&tablingMemberConstituency=Mid+Derbyshire", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2017-07-12&houseId=1&tablingMemberConstituency=Mid+Derbyshire&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2017-07-12&_page=0&houseId=1&tablingMemberConstituency=Mid+Derbyshire", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2017-07-12&houseId=1&tablingMemberConstituency=Mid+Derbyshire", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2017-07-12&houseId=1&tablingMemberConstituency=Mid+Derbyshire", "items" : [{"_about" : "http://data.parliament.uk/resources/751246", "AnsweringBody" : [{"_value" : "Department for Environment, Food and Rural Affairs"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/751246/answer", "answerText" : {"_value" : "<p>There are no plans to reinstate the contaminated land capital grants programme.<\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4098", "label" : {"_value" : "Biography information for Dr Thérèse Coffey"}
        }
        , "answeringMemberConstituency" : {"_value" : "Suffolk Coastal"}
        , "answeringMemberPrinted" : {"_value" : "Dr Thérèse Coffey"}
        , "dateOfAnswer" : {"_value" : "2017-07-17", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2017-07-17T16:46:13.277Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "13"}
      , "answeringDeptShortName" : {"_value" : "Environment, Food and Rural Affairs"}
      , "answeringDeptSortName" : {"_value" : "Environment, Food and Rural Affairs"}
      , "date" : {"_value" : "2017-07-12", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Land: Contamination"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Environment, Food and Rural Affairs, whether he has plans to reinstate the contaminated land capital grants programme.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4025", "label" : {"_value" : "Biography information for Mrs Pauline Latham"}
      }
      , "tablingMemberConstituency" : {"_value" : "Mid Derbyshire"}
      , "tablingMemberPrinted" : [{"_value" : "Pauline Latham"}
      ], "uin" : "4701"}
    , {"_about" : "http://data.parliament.uk/resources/751368", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/751368/answer", "answerText" : {"_value" : "<p>The Early Access to Medicines Schemes is a voluntary scheme. Companies are not paid for the medicines they supply into the scheme. However, the Government has recently announced new funding as part of a of a wider package of up to £86 million aimed at addressing barriers to uptake of innovation that were recommended in the Accelerated Access Review. Small to Medium Enterprises with products that meet the requirements for the Early Access to Medicines Scheme will be able to access this funding opportunity. Further announcements will be made on how small businesses can apply for this support. More information can be found at this link:<\/p><p> <\/p><p><a href=\"https://www.gov.uk/government/news/86-million-funding-announced-for-new-medicine-and-technology\" target=\"_blank\">https://www.gov.uk/government/news/86-million-funding-announced-for-new-medicine-and-technology<\/a><\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
        }
        , "answeringMemberConstituency" : {"_value" : "Winchester"}
        , "answeringMemberPrinted" : {"_value" : "Steve Brine"}
        , "dateOfAnswer" : {"_value" : "2017-07-20", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : {"_value" : "4700"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2017-07-20T15:14:36.357Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2017-07-12", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Medical Treatments: Innovation"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health, what funding is available for treatments which have been made available under the Early Access to Medicines Scheme after marketing authorisation but before the publication of NICE guidance.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4025", "label" : {"_value" : "Biography information for Mrs Pauline Latham"}
      }
      , "tablingMemberConstituency" : {"_value" : "Mid Derbyshire"}
      , "tablingMemberPrinted" : [{"_value" : "Pauline Latham"}
      ], "uin" : "4699"}
    , {"_about" : "http://data.parliament.uk/resources/751369", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/751369/answer", "answerText" : {"_value" : "<p>The Early Access to Medicines Schemes is a voluntary scheme. Companies are not paid for the medicines they supply into the scheme. However, the Government has recently announced new funding as part of a of a wider package of up to £86 million aimed at addressing barriers to uptake of innovation that were recommended in the Accelerated Access Review. Small to Medium Enterprises with products that meet the requirements for the Early Access to Medicines Scheme will be able to access this funding opportunity. Further announcements will be made on how small businesses can apply for this support. More information can be found at this link:<\/p><p> <\/p><p><a href=\"https://www.gov.uk/government/news/86-million-funding-announced-for-new-medicine-and-technology\" target=\"_blank\">https://www.gov.uk/government/news/86-million-funding-announced-for-new-medicine-and-technology<\/a><\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
        }
        , "answeringMemberConstituency" : {"_value" : "Winchester"}
        , "answeringMemberPrinted" : {"_value" : "Steve Brine"}
        , "dateOfAnswer" : {"_value" : "2017-07-20", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : {"_value" : "4699"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2017-07-20T15:14:36.603Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2017-07-12", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Medical Treatments: Innovation"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health, what plans he has to transfer the funding of medicines under the Early Access to Medicines Scheme from pharmaceutical companies to the NHS.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4025", "label" : {"_value" : "Biography information for Mrs Pauline Latham"}
      }
      , "tablingMemberConstituency" : {"_value" : "Mid Derbyshire"}
      , "tablingMemberPrinted" : [{"_value" : "Pauline Latham"}
      ], "uin" : "4700"}
    ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 3, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}